Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

10.070
+0.5956.28%
Volume:158.14M
Turnover:1.58B
Market Cap:116.03B
PE:25.37
High:10.160
Open:9.350
Low:9.350
Close:9.475
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:2.50
T/O Rate:1.37%
Dividend:0.29
Dividend Rate:2.88%
EPS(LYR):0.397
ROE:20.90%
ROA:10.70%
PB:2.64
PE(LYR):25.37
PS:3.17

Loading ...

CSPC Pharmaceutical Group (SEHK:1093) Could Be 26% Undervalued Following Three Phase III Updates

Simply Wall St.
·
Yesterday

CSPC Reports Blood Sugar Reduction in Phase III Diabetes Study

MT Newswires Live
·
Yesterday

CSPC Pharma Announces Positive Phase III Results for Weekly GLP-1 Candidate TG103 in Chinese Type 2 Diabetes Patients

Bulletin Express
·
Sep 30

CSPC Pharmaceutical (01093) Reveals Positive Phase III Results for Edaglutide Alfa Injection Combined with Metformin in Chinese Adults with Type 2 Diabetes at EASD 2026

Stock News
·
Sep 30

CSPC Pharmaceutical Group Stock Rallies 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 30

AI Drug Discovery Sector Heats Up: ChinaAMC Hang Seng Biotech (03069) Rises Over 4% Intraday, ChinaAMC Innovative Drugs (03525) Gains Over 3% in Afternoon Session

Stock News
·
Sep 30

CSPC Pharma Shares Rise Nearly 6% on String of R&D Updates Spanning mRNA Cancer Vaccines and Recombinant Protein Vaccines

Stock News
·
Sep 30

CSPC Hits 5-Week High on US FDA's Nod on Herpes Zoster Vaccine Trial

Reuters
·
Sep 30

Movement Alert|CSPC PHARMA Rises 3.48% in Regular Trading, Herpes Zoster Vaccine Receives US FDA Clinical Trial Approval

Market Focus
·
Sep 30

CSPC Pharma Wins FDA Nod to Initiate U.S. Trials for First Recombinant Herpes Zoster Vaccine

Bulletin Express
·
Sep 29

CSPC Pharmaceutical Initiates Phase IB Clinical Trial of Jmt206 Injection in China

Reuters
·
Sep 29

CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China

Stock News
·
Sep 29

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Stock News
·
Sep 29

Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval in U.S.

Reuters
·
Sep 29

CSPC Pharmaceutical - Phase Ib Trial to Evaluate Jmt206 Injection as Monotherapy or with Semaglutide in Obesity

THOMSON REUTERS
·
Sep 29

CSPC Pharmaceutical - Phase Ib Clinical Trial of Jmt206 Injection for Weight Management in Adult Patients Initiated at First Study Centre in China

THOMSON REUTERS
·
Sep 29

CSPC Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Sep 28

CSPC Pharmaceutical - Pharma's Sys6077 Injection Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Sep 28

CSPC PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 4.99%

HK Disclosure
·
Sep 28

Regulator Clarifies Insurers' Hong Kong Stock Connect ETF Investment Rules; Crealights' Southbound Stake Rises to 4.2%

Stock News
·
Sep 25